Physician

Leann Michelle Blankenship, M.D.

According to 2025 Medicare claims, Leann Blankenship, M.D. (NPI: 1659634772) practices hematology/oncology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Contra Costa, CA. This provider's primary affiliated billing organization is EPIC CARE (NPI: 1780107797; TIN: 821993796) and primary practice location at 94608-2038. Blankenship is affiliated with the Aledade 147 Hill Physicians MSSP Basic E (ACO ID: A5230), participating under the MSSP model.

Blankenship's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 717 traditional Medicare patients, billed 192,980 HCPCS/CPT codes, and received $2,829,682 in Medicare payments. The top billing code was 99443 (Telephone medical discussion with physician, 21-30 minutes). Part D data shows 1,808 prescription claims across 336 beneficiaries totaling $3,315,976 in drug costs, led by Ibrance (Palbociclib). DME data shows 26 claims. Open Payments data shows 198 records totaling $4,317. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $165,518 to $2,829,682. Similarly, Part D prescription costs have moved sharply higher in recent years, from $42,115 to $3,315,976. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $722 to $1,695.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	226	8,727	$165,518
2019	731	71,980	$1,148,677
2020	565	114,425	$1,659,437
2021	590	92,729	$1,172,029
2022	498	144,844	$1,848,279
2023	558	187,051	$2,576,726
2024	717	192,980	$2,829,682

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	36	$42,115
2016	25	169	$173,394
2017	44	265	$175,171
2018	42	255	$236,581
2019	110	435	$660,318
2020	139	844	$1,319,719
2021	213	935	$1,548,765
2022	235	1,386	$2,184,816
2023	295	1,522	$1,692,674
2024	336	1,808	$3,315,976

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$3,322
2019	N/R	35	$6,144
2020	N/R	91	$6,786
2021	N/R	68	$5,321
2022	N/R	N/R	N/R
2023	N/R	52	$12,186
2024	N/R	26	$801

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99443	Telephone medical discussion with physician, 21-30 minutes	304	554	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	342	571	$109
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	91	259	$69
36415	Insertion of needle into vein for collection of blood sample	266	879	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	230	747	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	44	1,232	$652,253
Imbruvica	Ibrutinib	18	504	$283,710
Pomalyst	Pomalidomide	12	336	$283,523
Tagrisso	Osimertinib Mesylate	16	480	$252,945
Lenalidomide	Lenalidomide	18	441	$208,748

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	11	$519
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	15	$282

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	198	$4,317	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Leann Michelle Blankenship, M.D.?

Tedicare shows public-source Medicare data for Leann Michelle Blankenship, M.D. (NPI 1659634772), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Leann Michelle Blankenship, M.D. have ACO affiliation data?

Leann Michelle Blankenship, M.D. is shown with ACO affiliation data for Aledade 147 Hill Physicians MSSP Basic E (MSSP, ACO ID A5230).

What billing organization is linked to Leann Michelle Blankenship, M.D.?

Leann Michelle Blankenship, M.D. is linked to EPIC CARE (billing NPI 1780107797) in the available physician profile data.

Does Leann Michelle Blankenship, M.D. have Open Payments data?

Leann Michelle Blankenship, M.D. has 198 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.